Laboratory Analytical Instruments Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Laboratory Analytical Instruments
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2018-10-11 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.44 | +71 | 12,784,684 | 0% | +$528 | |||||
| D | 2018-10-10 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $311.84 | -10,000 | 70,805 | -12% | -$3,118,424 | |||||
2018-10-10 | ILMN | Illumina Inc | Flatley Jay T | Dir | S - Sale | $321.58 | -3,300 | 389,604 | -1% | -$1,061,214 | ||||||
2018-10-09 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.29 | +34,896 | 12,784,613 | 0% | +$254,217 | ||||||
2018-10-01 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.56 | +24 | 12,749,717 | 0% | +$181 | ||||||
| D | 2018-08-21 | BNGO | Bionano Genomics, Inc | Barker David L | Dir | P - Purchase | $6.47 | +3,894 | 3,894 | New | +$25,194 | |||||
2018-10-01 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $369.61 | -2,100 | 72,335 | -3% | -$776,183 | ||||||
| D | 2018-10-01 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale+OE | $369.15 | -1,346 | 5,447 | -20% | -$496,876 | |||||
2018-10-02 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $20.91 | -2,995 | 1,173,068 | 0% | -$62,610 | ||||||
| D | 2018-10-01 | PKI | Perkinelmer Inc | Friel Robert F | Pres, CEO | S - Sale+OE | $97.05 | -150,612 | 572,657 | -21% | -$14,617,100 | |||||
2018-10-01 | PKI | Perkinelmer Inc | Butters Deborah A. | Please See Remarks | S - Sale | $97.70 | -3,266 | 6,189 | -35% | -$319,088 | ||||||
2018-09-27 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.53 | +52 | 12,749,693 | 0% | +$392 | ||||||
2018-09-26 | ILMN | Illumina Inc | Flatley Jay T | Dir | S - Sale | $360.81 | -3,300 | 392,904 | -1% | -$1,190,673 | ||||||
2018-09-25 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.97 | +2,940 | 12,779,311 | 0% | +$23,447 | ||||||
| D | 2018-09-24 | PKI | Perkinelmer Inc | Tereau Daniel R | Please See Remarks | S - Sale+OE | $96.58 | -3,308 | 6,784 | -33% | -$319,487 | |||||
2018-09-19 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $8.22 | +40 | 12,776,371 | 0% | +$329 | ||||||
2018-09-12 | ILMN | Illumina Inc | Flatley Jay T | Dir | S - Sale | $351.66 | -3,300 | 396,204 | -1% | -$1,160,478 | ||||||
2018-09-13 | A | Agilent Technologies Inc | Clark Paul N | Dir | S - Sale | $68.60 | -2,876 | 88,451 | -3% | -$197,294 | ||||||
2018-09-11 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $8.42 | +17 | 12,779,346 | 0% | +$143 | ||||||
| D | 2018-09-11 | A | Agilent Technologies Inc | Fields Heidi | Dir | S - Sale+OE | $67.73 | -5,482 | 65,290 | -8% | -$371,296 | |||||
| D | 2018-09-10 | MTD | Mettler Toledo International Inc/ | Spoerry Robert F | Dir | S - Sale+OE | $600.00 | -1,836 | 362,413 | -1% | -$1,101,600 | |||||
| D | 2018-09-10 | MTD | Mettler Toledo International Inc/ | De La Guerroniere Marc | Head of Eur, NA Market Orgs. | S - Sale+OE | $600.00 | -740 | 0 | -100% | -$444,000 | |||||
| D | 2018-09-10 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $347.07 | -10,000 | 70,805 | -12% | -$3,470,709 | |||||
| D | 2018-09-07 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale+OE | $345.14 | -1,346 | 5,793 | -19% | -$464,558 | |||||
| D | 2018-09-10 | PKI | Perkinelmer Inc | Corbett James | Please See Remarks | S - Sale+OE | $94.34 | -4,175 | 43,019 | -9% | -$393,870 | |||||
| D | 2018-09-06 | MTD | Mettler Toledo International Inc/ | Vadala Shawn | CFO | S - Sale+OE | $590.00 | -300 | 5,299 | -5% | -$177,000 | |||||
| DM | 2018-09-06 | MTD | Mettler Toledo International Inc/ | Heidingsfelder Michael | Head of Industrial | S - Sale+OE | $589.00 | -4,305 | 0 | -100% | -$2,535,645 | |||||
2018-09-05 | QTRX | Quanterix Corp | Hrusovsky E Kevin | COB, Pres, CEO | S - Sale | $14.53 | -17,909 | 1,176,063 | -1% | -$260,243 | ||||||
| M | 2018-09-05 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.85 | +201 | 12,948,380 | 0% | +$1,577 | |||||
| DM | 2018-09-05 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $586.78 | -2,873 | 41,761 | -6% | -$1,685,824 | |||||
2018-09-04 | ILMN | Illumina Inc | Stapley Marc | EVP Strategy, Corp Developmt | S - Sale | $352.05 | -1,000 | 24,425 | -4% | -$352,054 | ||||||
2018-09-04 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $353.66 | -2,100 | 74,435 | -3% | -$742,686 | ||||||
2018-09-04 | ILMN | Illumina Inc | Van Oene Mark | SVP Chief Commercial Officer | S - Sale | $354.18 | -1,091 | 11,126 | -9% | -$386,410 | ||||||
| D | 2018-08-31 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $583.50 | -1,000 | 41,761 | -2% | -$583,500 | |||||
2018-08-30 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $7.86 | +18 | 12,948,179 | 0% | +$141 | ||||||
2018-08-31 | PKI | Perkinelmer Inc | Lopardo Nicholas A | Dir | S - Sale | $92.28 | -2,700 | 47,177 | -5% | -$249,156 | ||||||
| DM | 2018-08-30 | MTD | Mettler Toledo International Inc/ | De La Guerroniere Marc | Head of Eur, NA Market Orgs. | S - Sale+OE | $581.91 | -7,555 | 0 | -100% | -$4,396,364 | |||||
| D | 2018-08-29 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $579.08 | -2,000 | 41,761 | -5% | -$1,158,155 | |||||
2018-08-28 | PRPO | Precipio, Inc. | Kirk Randal J | 10% | S - Sale | $0.41 | -24,600 | 1,334,521 | -2% | -$10,086 | ||||||
2018-08-29 | HBIO | Harvard Bioscience Inc | Green James W | Dir | P - Purchase | $5.74 | +2,500 | 156,187 | +2% | +$14,350 | ||||||
2018-08-29 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale | $5.77 | -8,889 | 321,169 | -3% | -$51,290 | ||||||
2018-08-28 | PKI | Perkinelmer Inc | Lopardo Nicholas A | Dir | S - Sale | $89.40 | -3,500 | 49,877 | -7% | -$312,900 | ||||||
| D | 2018-08-27 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $571.50 | -1,000 | 41,761 | -2% | -$571,500 | |||||
| D | 2018-08-27 | WAT | Waters Corp /de/ | Rae Elizabeth B | SVP, Global HR | S - Sale+OE | $190.62 | -4,000 | 12,520 | -24% | -$762,480 | |||||
| D | 2018-08-23 | BNGO | Bionano Genomics, Inc | Holmlin R. Erik | Pres, CEO | P - Purchase | $6.12 | +1,630 | 1,630 | New | +$9,984 | |||||
| D | 2018-08-23 | BNGO | Bionano Genomics, Inc | Borodkin Mark | COO | P - Purchase | $6.12 | +815 | 815 | New | +$4,992 | |||||
| D | 2018-08-23 | BNGO | Bionano Genomics, Inc | Twomey Christopher J | Dir | P - Purchase | $6.12 | +10,000 | 10,000 | New | +$61,250 | |||||
| D | 2018-08-16 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $570.00 | -500 | 41,761 | -1% | -$285,000 | |||||
2018-08-15 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.78 | +25,500 | 12,948,161 | 0% | +$172,880 | ||||||
2018-08-14 | COHR | Coherent Inc | Sobey Mark Stewart | EVP | S - Sale | $181.86 | -13,000 | 5,387 | -71% | -$2,364,170 | ||||||
| D | 2018-08-10 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $331.39 | -10,000 | 70,805 | -12% | -$3,313,861 | |||||
| D | 2018-08-09 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $585.00 | -500 | 41,761 | -1% | -$292,500 | |||||
2018-08-08 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.76 | +21 | 12,922,661 | 0% | +$142 | ||||||
| DM | 2018-08-07 | HBIO | Harvard Bioscience Inc | Duchemin Jeffrey | CEO | S - Sale+OE | $6.18 | -150,000 | 790,742 | -16% | -$927,170 | |||||
| D | 2018-08-07 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $6.08 | -100,015 | 349,286 | -22% | -$608,091 | |||||
| D | 2018-08-08 | PKI | Perkinelmer Inc | Sullivan Patrick J | Dir | S - Sale+OE | $86.19 | -12,672 | 38,752 | -25% | -$1,092,263 | |||||
| DM | 2018-08-07 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $587.67 | -1,500 | 41,761 | -3% | -$881,500 | |||||
2018-08-06 | PKI | Perkinelmer Inc | Lopardo Nicholas A | Dir | S - Sale | $85.60 | -3,505 | 53,347 | -6% | -$300,028 | ||||||
| DM | 2018-08-03 | MTD | Mettler Toledo International Inc/ | Donnelly William P | EVP | S - Sale+OE | $590.07 | -3,000 | 41,761 | -7% | -$1,770,200 | |||||
2018-08-02 | ILMN | Illumina Inc | Ostadan Omead | EVP Ops, Products, Strategy | S - Sale | $320.70 | -1,334 | 24,484 | -5% | -$427,814 | ||||||
2018-08-02 | ILMN | Illumina Inc | Stapley Marc | EVP Strategy, Corp Developmt | S - Sale | $324.80 | -1,000 | 25,425 | -4% | -$324,798 | ||||||
2018-08-02 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.36 | +29 | 13,202,853 | 0% | +$184 | ||||||
| D | 2018-08-02 | PKI | Perkinelmer Inc | Okun Andrew | Please See Remarks | S - Sale+OE | $82.18 | -14,045 | 8,884 | -61% | -$1,154,218 | |||||
| D | 2018-08-02 | PKI | Perkinelmer Inc | Goldberg Joel S | Please See Remarks | S - Sale+OE | $85.00 | -34,608 | 62,311 | -36% | -$2,941,680 | |||||
| DM | 2018-08-01 | PKI | Perkinelmer Inc | Friel Robert F | Pres, CEO | S - Sale+OE | $81.60 | -218,579 | 572,657 | -28% | -$17,836,032 | |||||
2018-08-01 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $327.41 | -2,100 | 76,535 | -3% | -$687,555 | ||||||
2018-07-31 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.40 | +2,692 | 13,202,824 | 0% | +$17,230 | ||||||
| D | 2018-07-27 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $5.54 | -62,514 | 361,801 | -15% | -$346,328 | |||||
2018-07-27 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.14 | +20,029 | 13,200,132 | 0% | +$123,071 | ||||||
2018-07-24 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale | $5.25 | -5,570 | 374,315 | -1% | -$29,243 | ||||||
| DM | 2018-07-23 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Dir | S - Sale+OE | $63.54 | -69,871 | 2,027,619 | -3% | -$4,439,758 | |||||
2018-07-23 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale | $311.15 | -500 | 6,139 | -8% | -$155,575 | ||||||
| M | 2018-07-19 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale | $5.25 | -2,565 | 379,885 | -1% | -$13,466 | |||||
| D | 2018-07-17 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Dir | S - Sale+OE | $63.50 | -31,353 | 2,027,619 | -2% | -$1,990,981 | |||||
| DM | 2018-07-12 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $5.25 | -10,207 | 382,450 | -3% | -$53,587 | |||||
2018-07-12 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $6.27 | +54 | 13,180,049 | 0% | +$339 | ||||||
| D | 2018-07-10 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $288.89 | -7,500 | 70,996 | -10% | -$2,166,701 | |||||
| DM | 2018-07-09 | HBIO | Harvard Bioscience Inc | Gagnon Robert E. | CFO | S - Sale+OE | $5.26 | -169,200 | 386,829 | -30% | -$889,527 | |||||
| M | 2018-07-09 | HBIO | Harvard Bioscience Inc | Duchemin Jeffrey | CEO | S - Sale | $5.33 | -40,000 | 790,742 | -5% | -$213,353 | |||||
| DM | 2018-07-09 | IART | Integra Lifesciences Holdings Corp | Essig Stuart | Dir | S - Sale+OE | $64.01 | -159,752 | 2,027,619 | -7% | -$10,225,409 | |||||
| M | 2018-06-22 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.80 | +95 | 13,180,049 | 0% | +$551 | |||||
| D | 2018-06-25 | EYPT | Eyepoint Pharmaceuticals, Inc. | Ew Healthcare Partners, L.P. | 10% | P - Purchase | $1.26 | +16,864,066 | 50,940,780 | +49% | +$21,333,043 | |||||
2018-07-02 | ILMN | Illumina Inc | Desouza Francis A | Pres, CEO | S - Sale | $276.14 | -2,100 | 82,271 | -2% | -$579,887 | ||||||
2018-06-21 | ILMN | Illumina Inc | Epstein Robert S | Dir | S - Sale | $288.45 | -500 | 6,639 | -7% | -$144,225 | ||||||
2018-06-19 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $4.72 | +10,593 | 13,179,954 | 0% | +$49,960 | ||||||
| M | 2018-06-15 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $4.80 | +121,549 | 13,169,361 | +1% | +$583,984 | |||||
2018-06-15 | IART | Integra Lifesciences Holdings Corp | Reuvers Daniel L. | CVP,PRES - CODMAN SPC SURGICAL | S - Sale | $66.97 | -1,000 | 25,009 | -4% | -$66,970 | ||||||
| M | 2018-06-12 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $4.95 | +149,715 | 13,047,812 | +1% | +$741,242 | |||||
2018-06-13 | BIO | Bio Rad Laboratories Inc | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $303.42 | -350 | 2,142 | -14% | -$106,197 | ||||||
2018-06-11 | ILMN | Illumina Inc | Stapley Marc | EVP Strategy, Corp Developmt | S - Sale | $285.18 | -1,446 | 26,425 | -5% | -$412,364 | ||||||
| D | 2018-06-11 | ILMN | Illumina Inc | Ronaghi Mostafa | SVP, CTO | S - Sale+OE | $284.83 | -10,500 | 70,996 | -13% | -$2,990,759 | |||||
| D | 2018-06-11 | A | Agilent Technologies Inc | Fields Heidi | Dir | S - Sale+OE | $66.47 | -5,000 | 65,170 | -7% | -$332,375 | |||||
| D | 2018-06-12 | A | Agilent Technologies Inc | Koh Boon Hwee | Dir | S - Sale+OE | $66.38 | -6,931 | 83,643 | -8% | -$460,099 | |||||
| M | 2018-06-07 | FLDM | Fluidigm Corp | Levin Capital Strategies, L.P. | Passive Investor, 10% | P - Purchase | $5.52 | +55,763 | 12,898,097 | 0% | +$307,627 | |||||
| D | 2018-06-07 | MTD | Mettler Toledo International Inc/ | Heidingsfelder Michael | Head of Industrial | S - Sale+OE | $590.00 | -2,562 | 0 | -100% | -$1,511,580 | |||||
| D | 2018-06-08 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale+OE | $595.00 | -700 | 2,778 | -20% | -$416,500 | |||||
| DM | 2018-06-06 | MTD | Mettler Toledo International Inc/ | Spoerry Robert F | Dir | S - Sale+OE | $582.80 | -5,355 | 362,413 | -1% | -$3,120,900 | |||||
| DM | 2018-06-06 | MTD | Mettler Toledo International Inc/ | Chu Wah-Hui | Dir | S - Sale+OE | $587.83 | -1,150 | 2,778 | -29% | -$676,000 | |||||
| D | 2018-06-05 | QTRX | Quanterix Corp | Orticerio Ernest | SVP Finance, Corporate Dev | S - Sale+OE | $17.15 | -25,000 | 53,802 | -32% | -$428,633 | |||||
2018-06-01 | ILMN | Illumina Inc | Ostadan Omead | EVP Ops, Products, Strategy | S - Sale | $274.61 | -1,335 | 25,818 | -5% | -$366,604 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |